| HOME >> BIOLOGY >> TECHNOLOGY |
-----------------------------------------------------------------------
(25,817) (64,368) (74,602) (324,762)
Financing activities:
Shares and warrants
issued for cash 17,345 23,106 52,502 326,358
Warrants exercised
for cash - - - 16,941
Options exercised for cash - - 627 7,669
Share issue costs (1,440) (2,221) (3,720) (24,646)
Issue (repayment) of
senior convertible
notes payable, net (924) (3,976) 42,790 38,512
Cash released from
(placed under)
restriction 6,403 5,298 (11,701) -
Paid to related parties - - - (234)
-----------------------------------------------------------------------
21,384 22,207 80,498 364,600
Investing activities:
Purchases of property and
equipment (49) (23) (490) (2,465)
Purchases of acquired
technology - - - (1,283)
Purchases of marketable
securities - (80) (22,999) (244,846)
Settlement of forward
exchange contracts 10 (102) (4,732) (4,824)
Maturities of marketable
securities - 23,079 67,651 240,677
-----------------------------------------------------------------------
(39) 22,874 39,430 (12,741)
Foreign exchange loss on
cash held in foreign
currency (2,410) (8
'/>"/>
| SOURCE Vasogen Inc. Copyright©2008 PR Newswire. All rights reserved |